Latest Insider Transactions at Enhabit, Inc. (EHAB)
This section provides a real-time view of insider transactions for Enhabit, Inc. (EHAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Enhabit, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Enhabit, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 11
2024
|
Barry P. Schochet Director |
BUY
Other acquisition or disposition
|
Direct |
7,325
+4.68%
|
$80,575
$11.49 P/Share
|
|
Jan 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,043
-1.86%
|
$10,430
$10.35 P/Share
|
|
Jan 01
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,928
-2.63%
|
$99,280
$10.35 P/Share
|
|
Jan 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,043
-2.35%
|
$10,430
$10.35 P/Share
|
|
Oct 04
2023
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,636
-2.83%
|
$13,088
$8.65 P/Share
|
|
Jul 01
2023
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,044
-1.77%
|
$11,484
$11.5 P/Share
|
|
Jul 01
2023
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-2.5%
|
$7,733
$11.5 P/Share
|
|
Jun 28
2023
|
Tina L. Brown Stevenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+36.24%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+28.23%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+19.73%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+29.9%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+26.76%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+29.53%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+30.9%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+46.53%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+30.24%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+46.53%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Susan La Monica Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+26.19%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+29.68%
|
$139,722
$11.81 P/Share
|
|
May 26
2023
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+9.26%
|
$22,000
$11.61 P/Share
|
|
May 22
2023
|
L Edward Shaw Jr Director |
BUY
Open market or private purchase
|
Direct |
10,000
+20.41%
|
$110,000
$11.98 P/Share
|
|
May 18
2023
|
Erin Hoeflinger Director |
BUY
Open market or private purchase
|
Direct |
2,100
+11.8%
|
$23,100
$11.82 P/Share
|
|
May 18
2023
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Open market or private purchase
|
Direct |
10,000
+18.41%
|
$110,000
$11.99 P/Share
|
|
May 17
2023
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+10.21%
|
$22,000
$11.8 P/Share
|
|
Mar 01
2023
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
35,001
+11.35%
|
-
|
|
Mar 01
2023
|
Crissy Buchanan Carlisle Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,340
+11.75%
|
-
|
|
Mar 01
2023
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,579
+17.01%
|
-
|
|
Mar 01
2023
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12,747
+15.46%
|
-
|
|
Mar 01
2023
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
8,763
+11.33%
|
-
|
|
Mar 01
2023
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,764
+33.33%
|
-
|
|
Mar 01
2023
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
17,158
+33.34%
|
-
|
|
Feb 25
2023
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-1.31%
|
-
|
|
Feb 25
2023
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,062
-0.73%
|
-
|
|
Feb 25
2023
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
345
-1.73%
|
-
|
|
Feb 25
2023
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
767
-1.35%
|
-
|
|
Feb 24
2023
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.39%
|
-
|
|
Feb 24
2023
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
789
-0.23%
|
-
|
|
Feb 24
2023
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.36%
|
-
|
|
Feb 20
2023
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.36%
|
-
|
|
Feb 20
2023
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-0.21%
|
-
|
|
Feb 20
2023
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.32%
|
-
|
|
Jan 02
2023
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-0.72%
|
-
|
|
Jan 02
2023
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,546
-0.93%
|
-
|
|
Jan 02
2023
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
743
-0.64%
|
-
|
|
Nov 18
2022
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
1,000
+6.03%
|
$12,000
$12.69 P/Share
|
|
Nov 09
2022
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+12.05%
|
$24,000
$12.75 P/Share
|
|
Nov 08
2022
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+13.7%
|
$24,000
$12.89 P/Share
|
|
Nov 08
2022
|
Leo I Higdon Jr Director |
BUY
Open market or private purchase
|
Indirect |
426
+5.1%
|
$5,538
$13.57 P/Share
|
|
Nov 07
2022
|
Gregory S Rush Director |
BUY
Open market or private purchase
|
Direct |
8,300
+33.34%
|
$99,600
$12.69 P/Share
|
|
Nov 04
2022
|
Gregory S Rush Director |
BUY
Open market or private purchase
|
Direct |
1,700
+17.01%
|
$20,400
$12.58 P/Share
|